Panagiota Voskou | Cognitive Neuroscience | Innovative Research Award

Innovative Research Award

Panagiota Voskou
National and Kapodistrian University of Athens, Greece
Panagiota Voskou
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 57046080700
Documents 14
Citations 147
h-index 8
Subject Area Neurology, Dementia, Neuropsychology, Legal Capacity, Cognitive Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0002-2690-0408

Panagiota Voskou is a Greek neurologist, researcher, educator, and postdoctoral candidate affiliated with the National and Kapodistrian University of Athens. Her academic and clinical career has focused extensively on dementia, medico-legal neurology, neuropsychological assessment, and legal capacity evaluation in neurodegenerative disorders. She is internationally recognized for the development and validation of the Testamentary Capacity Assessment Tool (TCAT), a specialized instrument designed for assessing testamentary capacity in patients with dementia and cognitive disorders.[1]

Abstract

This article presents the academic achievements, clinical expertise, and scientific contributions of Panagiota Voskou in the fields of neurology, dementia research, and neuropsychological assessment. Her work integrates clinical neuroscience with medico-legal evaluation, particularly focusing on testamentary capacity and cognitive competence in dementia. Through the development of the Testamentary Capacity Assessment Tool (TCAT), Dr. Voskou has contributed substantially to the advancement of structured legal-capacity assessment methodologies in neurodegenerative disorders. Her publications, conference presentations, educational activities, and international collaborations demonstrate an interdisciplinary approach combining neurology, psychiatry, geriatrics, and forensic medicine.[2]

Keywords

  • Neurology
  • Dementia
  • Neuropsychological Assessment
  • Testamentary Capacity
  • Legal Capacity
  • Cognitive Disorders
  • Alzheimer Disease
  • Movement Disorders
  • Clinical Neuroscience
  • Forensic Psychiatry

Introduction

The increasing prevalence of dementia and cognitive disorders worldwide has highlighted the importance of reliable clinical and medico-legal assessment methodologies. In this context, Panagiota Voskou has emerged as a prominent researcher specializing in the intersection between neurology and legal medicine. Her scientific work addresses the evaluation of cognitive competence, legal capacity, and neuropsychological functioning in individuals with neurodegenerative diseases.[3]

Voskou’s research activities include studies on dementia progression, neuropsychological predictors, migraine-associated disorders, neurodegeneration, and legal capacity assessment. She has participated extensively in international conferences organized by the European Academy of Neurology (EAN), Alzheimer’s Association International Conference (AAIC), World Congress of Neurology (WCN), and other scientific organizations dedicated to neuroscience and geriatric medicine.[4]

Research Profile

Voskou graduated from the Medical School of the National and Kapodistrian University of Athens with distinction and subsequently completed postgraduate and doctoral studies in mental health and dementia-related legal capacity assessment. She currently serves as a Specialist Neurologist at the General Hospital of Chalkida and continues her postdoctoral research on the validation of the Testamentary Capacity Assessment Tool within the Greek population.[5]

Her professional experience spans neurology, psychiatry, internal medicine, pediatric neurology, cognitive disorders, and forensic psychiatry. Voskou has also contributed significantly to medical education through postgraduate teaching programs, webinars, continuing education initiatives, and university-level e-learning activities related to medico-legal issues in dementia.[2]

Research Contributions

One of Voskou’s most notable scientific contributions is the development and validation of the Testamentary Capacity Assessment Tool (TCAT), which provides clinicians with a structured framework for evaluating testamentary competence in patients with dementia and cognitive decline.[1]

Her research contributions also include investigations into mild cognitive impairment, progression to Alzheimer disease or Lewy body dementia, headache disorders, migraine pathophysiology, movement disorders, stroke-related cognitive dysfunction, and legal implications of neurological disease.[3]

  • Development of TCAT for dementia-related legal assessment
  • Research on legal capacity in neurological diseases
  • Neuropsychological predictors in cognitive impairment
  • Migraine and neurodegenerative disease studies
  • Educational contributions in psychogeriatrics and neurology
  • Reviewer activities for international scientific journals

Publications

Voskou has authored and co-authored numerous peer-reviewed scientific publications indexed in internationally recognized databases including Scopus, Web of Science, and PubMed. Her work has appeared in journals related to neurology, geriatrics, psychiatry, neuropsychology, and dementia research.[4]

  1. “Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.” Journal of Alzheimer’s Disease.
  2. “Testamentary Capacity Assessment: Legal, Medical, and Neuropsychological Issues.” Journal of Geriatric Psychiatry and Neurology.
  3. “Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study.” Neurological Sciences.
  4. “State-of-the-Art Testamentary Capacity Assessment Tool (TCAT) in Dementia: A Review of Studies and Update Report.” Journal of Dementia and Alzheimer’s Disease.

Research Impact

The impact of Voskou’s work extends across clinical neurology, forensic psychiatry, geriatric medicine, and legal neuropsychology. Her TCAT framework has contributed to improved methodologies for evaluating testamentary competence and cognitive legal decision-making in dementia patients.[1]

Through her presentations at major international congresses, Voskou has promoted interdisciplinary dialogue on legal capacity assessment, neurodegenerative disease management, and ethical considerations in neurological care. Her involvement in educational programs and reviewer responsibilities further demonstrates her contribution to the scientific and academic community.[1]

Award Suitability

Panagiota Voskou demonstrates strong suitability for the Innovative Research Award due to her interdisciplinary scientific achievements and her pioneering contributions to medico-legal neurology. The development of the Testamentary Capacity Assessment Tool represents a clinically relevant innovation with applications in dementia evaluation, legal medicine, and neuropsychological assessment.[2]

Her academic productivity, international conference participation, educational leadership, and peer-reviewed publications collectively support her recognition within the global neuroscience research community. The integration of neuroscience and legal assessment in her work highlights a specialized area of innovation with growing relevance in aging populations and cognitive healthcare systems worldwide.[3]

Conclusion

Panagiota Voskou has established a distinguished academic and clinical profile in neurology, dementia research, and legal neuropsychology. Her scientific contributions, particularly in testamentary capacity assessment, represent meaningful advancements within the interdisciplinary fields of cognitive neuroscience and medico-legal evaluation. Through sustained research activity, international collaboration, teaching, and publication, she continues to contribute to the development of evidence-based neurological assessment methodologies and dementia care practices.[4]

References

  1. Voskou, P., et al. (2018). Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia. Journal of Alzheimer’s Disease.
    https://doi.org/10.3233/JAD-170297
  2. Voskou, P., Douzenis, A., Economou, A., Papageorgiou, S.G. (2026). State-of-the-Art Testamentary Capacity Assessment Tool (TCAT) in Dementia.
    https://doi.org/10.3390/jdad3020025
  3. Voskou, P., et al. (2018). Testamentary Capacity Assessment: Legal, Medical, and Neuropsychological Issues.
    https://doi.org/10.1177/0891988717746508
  4. European Academy of Neurology. (2025). Congress participation records and scientific presentations.
  5. National and Kapodistrian University of Athens. (2025). Official Postdoctoral Certification

Vijaya Narne | Behavioral Neuroscience | Best Researcher Award

Best Researcher Award

Vijaya Narne
Affiliation King Khalid University
Country Saudi Arabia / India
Scopus ID 23103700400
Documents 41
Citations 418
h-index 11
Subject Area Audiology, Hearing Sciences, Auditory Neuroscience, Behavioral Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0002-6531-8015

Vijaya Narne
King Khalid University, Saudi Arabia

Vijaya Narne, is an internationally recognized researcher and academician in the field of audiology and hearing sciences. His research contributions encompass auditory perception, psychoacoustics, electrophysiology, speech perception in noise, hearing impairment diagnostics, auditory processing disorders, and language-specific rehabilitation tools. Over the course of his academic and research career, he has contributed extensively to the advancement of hearing science through interdisciplinary collaborations, novel diagnostic developments, and translational clinical research initiatives.[1]

Abstract

This article presents a scholarly overview of the academic achievements, scientific contributions, and professional accomplishments of Vijaya Kumar Narne in the field of audiology and hearing sciences. His multidisciplinary research has significantly contributed to the understanding of auditory perception, auditory neuropathy spectrum disorders, psychoacoustic modeling, hearing aid rehabilitation, electrophysiology, and language-specific diagnostic methodologies. Through numerous peer-reviewed publications, funded research projects, and collaborative international investigations, Narne has demonstrated sustained contributions toward evidence-based hearing healthcare and auditory science innovation.[2]

Keywords

Audiology, Hearing Sciences, Auditory Neuroscience, Psychoacoustics, Auditory Processing Disorders, Hearing Rehabilitation, Speech Perception, Electrophysiology, Auditory Neuropathy, Hearing Aid Research, Auditory Stream Segregation, Clinical Audiology, Speech-in-Noise Testing, Hearing Diagnostics, Language-Specific Audiology.

Introduction

The discipline of audiology has experienced substantial advancements over recent decades due to innovations in auditory neuroscience, psychoacoustics, electrophysiology, and digital hearing technologies. Within this evolving scientific landscape, researchers who bridge clinical practice with experimental research play an essential role in improving hearing healthcare outcomes. Vijaya Kumar Narne has emerged as a prominent contributor in these domains through his extensive research on auditory processing, hearing impairment diagnostics, and auditory rehabilitation systems.[3]

His academic journey spans leading institutions including the All India Institute of Speech and Hearing, Macquarie University, South Denmark University, Indian Institute of Technology Kanpur, and King Khalid University. These affiliations have enabled international collaborative research in auditory modeling, speech perception, electrophysiological assessment, and hearing aid rehabilitation methodologies.[4]

Research Profile

Narne completed in Audiology at the All India Institute of Speech and Hearing, Mysore, India, where his doctoral research investigated speech perception with spectral and temporal modifications in individuals with auditory dyssynchrony. His work established a strong scientific foundation in auditory processing mechanisms and hearing perception disorders.[5]

Over the course of his academic career, Narne has held several major research and teaching positions internationally. His expertise spans auditory perception modeling, psychoacoustics, hearing aid rehabilitation, auditory electrophysiology, and language-specific auditory diagnostics. He has supervised postgraduate dissertations, collaborated in multidisciplinary research teams, and contributed toward the development of clinically applicable diagnostic protocols and rehabilitation tools.[5]

  • Assistant Professor in Audiology at King Khalid University, Saudi Arabia
  • Senior Project Scientist at Indian Institute of Technology Kanpur
  • Postdoctoral Fellow at South Denmark University
  • Lecturer and Reader at All India Institute of Speech and Hearing
  • Research Audiologist at Macquarie University, Australia

Research Contributions

Narne’s scientific contributions are characterized by interdisciplinary integration between psychoacoustics, auditory neuroscience, hearing diagnostics, and clinical rehabilitation systems. His work on spectral ripple discrimination and spectro-temporal ripple testing has significantly contributed to understanding auditory frequency selectivity and speech perception in noise.[1]

He has also contributed extensively to the development of language-specific speech perception tests and auditory diagnostic tools for multiple Indian languages including Kannada, Malayalam, Telugu, and Hindi. These developments have improved accessibility and reliability of hearing assessments for linguistically diverse populations.[2]

Additionally, his research has advanced the understanding of auditory stream segregation, hearing aid outcomes, cortical auditory evoked potentials, and auditory processing disorders. Several of his projects received support from major funding bodies including ICMR, DST, AIISH, and international hearing research collaborations.[5]

Publications

Narne has authored and co-authored numerous publications in internationally recognized journals specializing in audiology, hearing science, auditory neuroscience, and speech-language pathology. His studies are widely cited in areas related to auditory perception, hearing diagnostics, and speech processing.[1]

  • Narne, V. K., & Moore, B. C. J. (2020). Narrow-band ripple glide discrimination and frequency selectivity. Hearing Research.
  • Narne, V. K. (2013). Temporal processing and speech perception in noise by listeners with auditory neuropathy. PLoS One.
  • Jain, S., Narne, V. K., & Moore, B. C. J. (2022). High-frequency hearing sensitivity and auditory stream segregation. Journal of the Acoustical Society of America.
  • Peter, V., Narne, V. K., Purdy, S. C., & McMahon, C. (2014). Assessing spectral and temporal processing using ripple-based measures. Journal of the American Academy of Audiology.
  • Narne, V. K., & Vanaja, C. S. (2008). Speech identification and cortical potentials in individuals with auditory neuropathy. Behavioral and Brain Functions.

Research Impact

The research impact of Narne extends across clinical audiology, auditory neuroscience, speech perception research, and hearing rehabilitation technologies. His investigations into psychoacoustic processing and auditory stream segregation have provided clinically relevant insights into speech recognition challenges experienced by hearing-impaired populations.[1]

His collaborative international studies with researchers including Prof. Brian C. J. Moore have contributed to the development of advanced auditory assessment methodologies and psychoacoustic-inspired hearing evaluation systems. Furthermore, his work in hearing aid outcome prediction and hearing rehabilitation databases has strengthened evidence-based audiological care frameworks.[2]

Award Suitability

Vijaya Kumar Narne demonstrates strong suitability for recognition in the field of audiology and hearing sciences due to his sustained academic excellence, internationally collaborative research, interdisciplinary innovation, and commitment to clinical translation. His contributions span fundamental auditory science, hearing disorder diagnostics, language-specific rehabilitation tools, and evidence-based clinical methodologies.[3]

His achievements in funded research, peer-reviewed scholarship, postgraduate mentorship, software development, and auditory diagnostic innovation collectively establish a significant academic profile aligned with global standards of scientific excellence and healthcare research advancement.

Conclusion

Vijaya Kumar Narne has established an influential academic and research career within the field of audiology and hearing sciences. His interdisciplinary investigations, clinical innovations, and international collaborations have advanced scientific understanding of auditory processing, hearing rehabilitation, and psychoacoustic diagnostics. Through sustained research productivity, mentorship, and translational scientific contributions, he continues to contribute meaningfully toward global hearing healthcare research and auditory science development.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Vijaya Kumar Narne, Author ID 23103700400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23103700400
  2. ORCID. (n.d.). Vijaya Kumar Narne Research Profile.
    https://orcid.org/0000-0002-6531-8015
  3. Narne, V. K. (2013). Temporal processing and speech perception in noise by listeners with auditory neuropathy. PLoS One.
    https://doi.org/10.1371/journal.pone.0055995
  4. Narne, V. K., & Moore, B. C. J. (2020). Narrow-band ripple glide discrimination and frequency selectivity. Hearing Research.
    https://doi.org/10.1016/j.heares.2020.107910
  5. Jain, S., Narne, V. K., & Moore, B. C. J. (2022). High-frequency hearing sensitivity and auditory stream segregation. Journal of the Acoustical Society of America.
    https://doi.org/10.1121/10.0012917

Shan Ping Yu | Translational Neuroscience | Innovative Research Award

Innovative Research Award

Shan Ping Yu, 
Emory University School of Medicine, Atlanta, Georgia, United States

Shan Ping Yu
Affiliation Emory University School of Medicine
Country United States
Scopus ID 36157350300
Documents 194
Citations 14,194
h-index 62
Subject Area Neuroscience, Stroke Research, Stem Cell Biology, Neurodegeneration, Translational Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0003-1335-1398

Shan Ping Yu, is an internationally recognized neuroscientist and physician-scientist affiliated with the Department of Anesthesiology at Emory University School of Medicine. His research career spans several decades and encompasses fundamental and translational investigations in neuroprotection, stroke biology, stem cell therapeutics, ion channel regulation, neurodegenerative disorders, and cellular signaling mechanisms. Through leadership in academic medicine, editorial service, grant review activities, and mentorship, Yu has contributed substantially to contemporary neuroscience research and regenerative medicine initiatives.[1]

Abstract

This academic article examines the professional achievements and scientific contributions of Shan Ping Yu, MD/PhD, whose multidisciplinary research has significantly influenced the fields of neuroscience, neurodegenerative disease biology, stroke pathology, and regenerative medicine. Yu’s investigations into ion channel signaling, neural cell death mechanisms, stem cell therapeutics, and neuroinflammation have contributed to improved understanding of brain injury and neural repair processes. His leadership roles at Emory University and multiple international scientific organizations reflect sustained engagement in advancing translational neuroscience research. The article further evaluates Yu’s publication record, editorial leadership, peer-review service, mentoring activities, and global academic collaborations in the context of scientific recognition and award suitability.[2]

Keywords

  • Neuroscience
  • Stroke Research
  • Neurodegeneration
  • Stem Cell Therapy
  • Ion Channels
  • Cell Death Mechanisms
  • Regenerative Medicine
  • Brain Injury
  • Translational Neuroscience
  • Neural Repair

Introduction

The advancement of neuroscience and neurodegenerative disease research relies heavily on interdisciplinary approaches integrating molecular biology, pharmacology, stem cell science, and translational medicine. Shan Ping Yu has contributed to these developments through extensive investigations into ischemic brain injury, neuronal cell death, neuroprotection, and stem cell-mediated recovery pathways. His scientific career spans academic appointments at Washington University, the Medical University of South Carolina, and Emory University, where he currently serves as Asa Griggs Candler Endowed Professor with tenure.[1]

Yu’s work has also emphasized the clinical relevance of molecular neuroscience discoveries, particularly in relation to stroke, traumatic brain injury, and Alzheimer’s disease research. His studies on ion channels and neuroinflammation have contributed to broader understanding of neuronal survival and regenerative signaling mechanisms.[3]

Research Profile

Shan Ping Yu obtained his MD and MS degrees from the Capital Institute of Medicine in Beijing, China, followed by a PhD from the State University of New York at Stony Brook. His postdoctoral training at the Howard Hughes Medical Institute further strengthened his expertise in neurobiology and cellular signaling mechanisms. Yu later established an internationally recognized research program focused on ischemic brain injury and neuroregeneration.[4]

At Emory University School of Medicine, Yu has led multidisciplinary projects examining molecular pathways involved in neuronal injury and neural repair. His research integrates experimental neuroscience with translational therapeutic development, particularly in stem cell-based interventions and neuroprotective pharmacology.[5]

Research Contributions

Yu has contributed substantially to the understanding of neuronal apoptosis, necrosis, oxidative stress signaling, and ionic dysregulation during cerebral ischemia. His investigations into potassium and calcium channel modulation in neuronal injury have influenced experimental stroke therapeutics and neuroprotective strategies.[5]

Another major area of contribution involves stem cell therapy for neurological disorders. Yu’s collaborative studies explored mechanisms by which stem cells facilitate neural repair and functional recovery following stroke and traumatic brain injury. These investigations have informed broader regenerative medicine strategies aimed at restoring neural circuitry after injury.[4]

Publications

Yu’s publication portfolio includes numerous peer-reviewed articles in neuroscience, pharmacology, neurochemistry, and regenerative medicine journals. His work has appeared in internationally recognized journals including Stroke, Journal of Neuroscience, PNAS, Cell Death & Disease, and Translational Stroke Research.[2]

Research Impact

Yu’s scientific impact extends across neuroscience, regenerative medicine, and translational stroke research communities. His participation in NIH, NSF, VA, and international grant review panels demonstrates recognition as an authority in neurobiology and neurological disease research. He has also supervised postdoctoral fellows and junior investigators who subsequently obtained faculty appointments and research leadership positions internationally.[1]

His mentorship activities and commitment to diversity and inclusion in STEM education have contributed to career advancement opportunities for minority scholars and international researchers. Yu’s involvement with the PATHs AGEP Alliance and mentorship of early-career investigators highlights sustained contributions to academic workforce development.[2]

Award Suitability

Shan Ping Yu’s research career demonstrates sustained excellence in neuroscience and neurodegenerative disease investigation. His extensive publication record, international scientific collaborations, editorial leadership, conference organization, grant review participation, and mentoring contributions collectively support recognition within advanced scientific award categories. His work has influenced both experimental neuroscience research and translational therapeutic development in stroke and neurodegeneration.[2]

The breadth of Yu’s contributions across academia, research administration, and scientific mentorship aligns strongly with criteria commonly associated with lifetime achievement, excellence in neuroscience research, and translational medicine awards.[3]

Conclusion

Shan Ping Yu, MD/PhD, has established a distinguished international reputation in neuroscience and regenerative medicine through decades of scholarly achievement, translational research, and scientific leadership. His work in neuroprotection, stem cell therapy, neurodegeneration, and stroke biology has contributed to improved understanding of neurological disease mechanisms and therapeutic strategies. Through mentorship, peer-review service, conference organization, and editorial activities, Yu has also strengthened global neuroscience research networks and academic training initiatives.[4]

References

  1. Emory University School of Medicine. (2025). Faculty Curriculum Vitae: Shan Ping Yu, MD/PhD.
  2. Elsevier. (n.d.). Scopus author details: Shan Ping Yu, Author ID 36157350300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36157350300
  3. ScienceDaily. (2021). Alternative model of Alzheimer’s emphasizes different mechanisms leading to neurodegeneration.
  4. State University of New York at Stony Brook. Postdoctoral and doctoral research records related to neuroscience training.
  5. Emory University School of Medicine. Department of Anesthesiology faculty profile and research overview.

Nazia Karsan | Clinical Neuroscience | Innovative Research Award

Innovative Research Award

Nazia Karsan
King’s College London, United Kingdom
Nazia Karsan
Affiliation King’s College London
Country United Kingdom
Scopus ID 55441531700
Documents 50
Citations 1,304
h-index 21
Subject Area Clinical Neuroscience, Neurology, Migraine Research
Event World Neuroscientists Awards
ORCID 0000-0002-6946-5637

Nazia Karsan is a British neurologist, clinical neuroscientist, and migraine researcher affiliated with King’s College London and multiple National Health Service institutions in the United Kingdom. Her research contributions have focused extensively on migraine pathophysiology, neuroimaging, trigeminovascular mechanisms, headache disorders, and translational neuroscience. She has contributed to advancing the understanding of migraine premonitory symptoms, neurovascular signaling, and functional imaging biomarkers in neurological disorders.[1]

Abstract

This academic article presents a scholarly overview of the clinical and scientific contributions of Nazia Karsan in the fields of neurology and migraine neuroscience. Her research has significantly contributed to the understanding of migraine pathophysiology, particularly the premonitory and postdrome phases of migraine attacks, neurovascular signaling, functional neuroimaging, and translational therapeutics. Through collaborative research with international headache experts and multidisciplinary neurological teams, Karsan has advanced evidence-based approaches to migraine diagnosis, neuroimaging interpretation, and targeted pharmacotherapy.[2]

Keywords

  • Clinical Neuroscience
  • Migraine Research
  • Neurology
  • Headache Disorders
  • Functional Neuroimaging
  • Premonitory Symptoms
  • CGRP Therapeutics
  • Translational Medicine
  • Neurovascular Mechanisms

Introduction

Migraine remains one of the most prevalent neurological disorders worldwide, requiring continuous advancements in diagnostic precision, therapeutic development, and mechanistic understanding. Nazia Karsan has emerged as a leading contributor to this field through extensive clinical research, neuroimaging investigations, and translational neuroscience studies. Her academic career combines clinical neurology practice with high-impact headache research at King’s College London and associated healthcare institutions.[3]

Her scientific investigations have explored functional brain connectivity, migraine triggers, cranial autonomic symptoms, glutamatergic signaling, nitric oxide-mediated pathways, and pediatric migraine phenotyping. These contributions have provided deeper insight into migraine biology and the development of targeted therapeutic strategies.[4]

Research Profile

Karsan completed her MBBS with Merit in Clinical Practice at the Royal Free and University College Medical School in 2008 and earned a First Class Honours BSc in Neuroscience from University College London in 2006. She subsequently completed a PhD in Clinical Neuroscience at King’s College London in 2018, focusing on migraine mechanisms and neuroimaging research.[5]

She has held academic and clinical appointments including Consultant Neurologist at Lewisham and Greenwich NHS Trust, Honorary Consultant Adult Neurologist at Great Ormond Street Hospital for Children, and Postdoctoral Clinical Research Fellow within the Headache Group at King’s College London.[2]

Research Contributions

Karsan’s research contributions have centered on the neurobiological and vascular mechanisms involved in migraine pathogenesis. Her studies on calcitonin gene-related peptide (CGRP), acid-sensing ion channels, and nitric oxide signaling have supported the development of novel therapeutic strategies for migraine prevention and management.[4] Her neuroimaging investigations using functional magnetic resonance imaging and arterial spin labeling techniques have identified regional cerebral perfusion changes associated with migraine premonitory phases and triggered attacks. These findings have contributed to the broader understanding of migraine as a complex neurovascular disorder rather than solely a pain condition.[3]

Karsan has also contributed to pediatric headache medicine through studies examining migraine phenotyping in children and adolescents. Her work has highlighted the significance of early symptom recognition and non-painful manifestations in clinical diagnosis and management.[5]

Publications

  • Karsan N and Goadsby PJ. Biological insights from premonitory symptoms of migraine. Nature Reviews Neurology, 2018.
  • Karsan N and Goadsby PJ. Migraine: beyond pain. Practical Neurology, 2021.
  • Karsan N and Goadsby PJ. New oral drugs for migraine. CNS Drugs, 2022.
  • Karsan N et al. Regional cerebral perfusion during the premonitory phase of triggered migraine. Headache, 2023.
  • Karsan N. Pathophysiology of migraine. Continuum, 2024.
  • Karsan N and Goadsby PJ. Intervening in the Premonitory Phase to Prevent Migraine. CNS Drugs, 2024.
  • Karsan N et al. Glutamate as a therapeutic substrate in migraine. International Journal of Medical Sciences, 2025.

Research Impact

Karsan’s work has received international recognition within neurology and headache medicine communities. Her research has been presented at the American Academy of Neurology, International Headache Society Congress, Migraine Trust International Symposium, and European Headache Congress.[1] She has received multiple awards including the International Headache Society Early Career Headache Science Award, American Headache Society Early Career Lecture Award, and Association of British Neurologists Top Poster distinctions. These recognitions reflect the scientific and translational significance of her contributions to clinical neuroscience.[1]

Award Suitability

Nazia Karsan demonstrates strong suitability for international recognition in clinical neuroscience and migraine research due to her sustained academic productivity, translational clinical investigations, interdisciplinary collaborations, and impact on headache medicine. Her work bridges laboratory neuroscience, neuroimaging, clinical neurology, and therapeutic innovation, contributing to improved understanding and management of migraine disorders.[2] Her contributions to migraine pathophysiology, pediatric neurology, and neurovascular signaling continue to influence both clinical practice and future research directions in headache medicine.[3]

Conclusion

Nazia Karsan has established an internationally recognized academic profile through her extensive contributions to neurology and migraine neuroscience. Her work has enhanced scientific understanding of migraine mechanisms, neuroimaging biomarkers, and therapeutic pathways while supporting advances in patient-centered headache management. Her multidisciplinary achievements demonstrate substantial merit for academic distinction and international research recognition.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Dr Nazia Karsan, Author ID 55441531700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55441531700
  2. Karsan N, Goadsby PJ. Biological insights from premonitory symptoms of migraine. Nature Reviews Neurology, 2018.
    https://doi.org/10.1038/s41582-018-0098-4
  3. Karsan N and Goadsby PJ. Migraine: beyond pain. Practical Neurology, 2021.
  4. Karsan N et al. Molecular mechanisms of migraine: nitric oxide, monoamines and vasoactive peptides. International Journal of Medical Sciences, 2023.
  5. King’s College London. Clinical Neuroscience Research Profile of Dr Nazia Karsan.

John S Lyons | Clinical Neuroscience | Innovative Research Award

Innovative Research Award

John S. Lyons
University of Chicago
John S. Lyons
Affiliation University of Chicago
Country United States
Google Scholar ID hcKnlF8AAAAJ&hl
Documents 415
Citations 17,325
h-index 72
Subject Area Clinical Neuroscience
Event World Neuroscientists Awards

The Innovative Research Award recognizes distinguished academic leadership and sustained scholarly contributions in the field of clinical neuroscience and behavioral health research. John S. Lyons of the University of Chicago is internationally recognized for advancing evidence-based assessment systems, outcomes management methodologies, and population-focused mental health strategies across healthcare and public service systems.[1] His research and implementation initiatives have influenced mental health policy, child welfare systems, trauma-informed care frameworks, and integrated clinical assessment methodologies in multiple jurisdictions worldwide.[2]

Abstract

John S. Lyons has contributed extensively to the development of clinical assessment methodologies, integrated behavioral health systems, and evidence-based decision support tools within public mental health and child welfare systems. His academic work has focused on translational health services research, trauma-informed systems of care, and outcomes management frameworks designed to improve policy implementation and service delivery.[3] Through more than four hundred indexed scholarly works and significant interdisciplinary collaborations, Lyons has influenced both academic research and applied healthcare systems internationally.[4]

Keywords

  • Clinical Neuroscience
  • Behavioral Health
  • Child and Adolescent Mental Health
  • Evidence-Based Assessment
  • Outcomes Management
  • Trauma-Informed Care
  • Mental Health Policy
  • Public Health Systems
  • Psychiatric Services Research
  • Communimetrics

Introduction

John S. Lyons is a Professor of Psychiatry and Behavioral Neurosciences at the University of Chicago and has held numerous leadership positions in psychiatry, public health, and health services research.[5] His professional career has been associated with the advancement of structured assessment tools for children, adolescents, adults, and families within behavioral healthcare systems. Lyons is widely recognized for developing the Child and Adolescent Needs and Strengths (CANS) framework and related evidence-based assessment systems utilized in healthcare, social services, and child welfare agencies.

His interdisciplinary research integrates psychiatry, psychology, health policy, and implementation science. Over several decades, his work has contributed to system redesign initiatives across numerous states and institutions, emphasizing equitable healthcare delivery, outcomes measurement, and collaborative decision-making in public mental health systems.

Research Profile

Lyons earned academic qualifications in psychology and clinical methods from the University of Illinois at Chicago and subsequently served in faculty and leadership positions at Northwestern University, the University of Ottawa, the University of Kentucky, and the University of Chicago. His scholarly profile reflects extensive engagement in psychiatric outcomes research, healthcare quality assessment, and community mental health evaluation.

The researcher has directed and participated in numerous federally and institutionally funded projects involving mental health systems redesign, behavioral healthcare analytics, and implementation science initiatives.These projects include collaborations with public health agencies, state departments, Medicaid systems, and child welfare organizations across the United States and Canada.

  • Professor of Psychiatry & Behavioral Neurosciences at the University of Chicago
  • Director of the Center for Innovation in Population Health
  • Developer of the CANS, FAST, and ANSA assessment systems
  • Principal investigator for multiple public mental health initiatives
  • Contributor to trauma-informed systems of care and healthcare transformation research

Research Contributions

A major contribution of Lyons has been the development and international dissemination of communimetric approaches to assessment and outcomes management. His work has emphasized practical measurement systems that facilitate communication among clinicians, policymakers, and service providers.

His scholarship has also addressed the integration of trauma-informed care within child welfare and behavioral health systems. Studies conducted by Lyons and collaborators have examined the role of resilience, adverse childhood experiences, treatment outcomes, and service accessibility within youth mental health programs.

Lyons additionally contributed to research on psychiatric service utilization, emergency mental health screening, residential treatment outcomes, healthcare disparities, and integrated biopsychosocial models in clinical care. His publications frequently bridge research, clinical implementation, and policy application.

  • Development of the Child and Adolescent Needs and Strengths (CANS) framework
  • Advancement of Transformational Collaborative Outcomes Management (TCOM)
  • Research on trauma-informed child welfare systems
  • Implementation of evidence-based mental health assessment systems
  • Health policy and systems redesign consultation across multiple states

Publications

John S. Lyons has authored and co-authored books, manuals, and peer-reviewed articles spanning psychiatry, behavioral health systems, public health policy, and clinical outcomes management.Selected notable publications include:

  • Transformational Collaborative Outcomes Management: The Business of Personal Change (2022)
  • Communimetrics: A Communication Theory of Measurement in Human Services (2009)
  • “Transformational Collaborative Outcomes Management (TCOM): A Framework to Bridge the Gap Between Research, Practice, and Policy in Health Systems” (2024)
  • “Creating the Necessary Infrastructure for a Trauma-Informed System of Care for Children and Youth” (2023)
  • “Evaluation of Telehealth in Child Behavioral Health Services Delivery During the COVID-19 Pandemic” (2023)
  • “The HEADS-ED: A Rapid Mental Screening Tool for Pediatric Patients in the Emergency Department” (2012)

Many of these publications have contributed to the understanding of psychiatric service delivery, trauma-informed care systems, clinical decision support methodologies, and integrated healthcare models.

Research Impact

The scholarly impact of John S. Lyons is reflected in extensive citation metrics, a high h-index, and broad adoption of his assessment frameworks across clinical and public service settings.His research has informed service planning, healthcare quality assessment, trauma-informed policy implementation, and evidence-based behavioral health interventions.

The CANS and related assessment models developed by Lyons are used in numerous healthcare and child welfare systems internationally, supporting structured communication, treatment planning, and outcomes evaluation. His work has also influenced academic discussions concerning integrated care systems, patient-centered outcomes research, and public mental health reform.

  • 415 scholarly documents indexed
  • 17,325 academic citations
  • h-index of 72
  • International implementation of assessment frameworks
  • Extensive interdisciplinary and policy-oriented collaborations

Award Suitability

John S. Lyons demonstrates strong suitability for recognition through the Innovative Research Award due to his sustained academic productivity, translational research contributions, and measurable influence on healthcare systems and mental health policy. His work has consistently integrated research evidence with practical implementation models, facilitating improvements in behavioral healthcare planning and clinical outcomes assessment.

The interdisciplinary nature of his scholarship, combined with decades of leadership in mental health services research and public systems redesign, aligns with the objectives of the World Neuroscientists Awards initiative in recognizing impactful scientific and clinical innovation.

Conclusion

John S. Lyons has established a distinguished academic and professional record in clinical neuroscience, behavioral health systems, and psychiatric outcomes research. His contributions to evidence-based assessment frameworks, trauma-informed care systems, and public mental health policy have had enduring influence across academic, clinical, and governmental sectors.Through extensive scholarly publications, systems-level innovations, and interdisciplinary collaborations, Lyons continues to contribute significantly to the advancement of behavioral healthcare research and implementation science.

References

  1. University of Chicago. (n.d.). Faculty profile: John S. Lyons.
    https://psychiatry.uchicago.edu/
  2. Altschuler, M.R., & Lyons, J.S. (2024). Transformational Collaborative Outcomes Management (TCOM): A Framework to Bridge the Gap Between Research, Practice, and Policy in Health Systems.
    https://doi.org/10.61545/JHSE-1-251
  3. Lyons, J.S., Fernando, A.D. (2023). Creating the necessary infrastructure for a trauma-informed system of care for children and youth.
    https://doi.org/10.3389/fpsyg.2023.1129197
  4. Riley, E.N., Cordell, K.D., Shimshock, S.M., Perez Figueroa, R.E., Lyons, J.S., Vsevolozhskaya, O.A. (2023). Evaluation of telehealth in child behavioral health services delivery during the COVID-19 pandemic.
    https://doi.org/10.1176/appi.ps.20220141
  5. World Neuroscientists Awards. Recognition criteria for innovative interdisciplinary neuroscience research and impact.
    https://neuroscientists.net/

Nicola Cosentino | Emerging Areas in Neuroscience | Research Excellence Award

Research Excellence Award

Nicola Cosentino
Centro Cardiologico Monzino, Italy
Nicola Cosentino
Affiliation Centro Cardiologico Monzino
Country Italy
Scopus ID 6602546905
Documents 162
Citations 2,966 citations by 2,688 documents
h-index 30
Subject Area Emerging Areas in Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0002-8628-3106

Nicola Cosentino is an Italian physician-scientist and cardiovascular researcher affiliated with Centro Cardiologico Monzino, Milan, Italy. His scholarly work has contributed extensively to the understanding of acute myocardial infarction, cardiovascular inflammation, cardio-renal interactions, translational cardiology, and precision medicine approaches in coronary artery disease. Through multidisciplinary collaborations, clinical investigations, and translational research programs, Cosentino has contributed to the advancement of cardiovascular diagnostics, biomarker discovery, and prognostic stratification methodologies in modern clinical cardiology.[1]

He has authored and co-authored more than 150 peer-reviewed scientific publications indexed in major international databases and has participated in several multicenter clinical trials and international cardiovascular initiatives. His research activities integrate acute cardiovascular care, heart failure management, metabolic disorders, inflammation biology, and innovative therapeutic strategies associated with cardiovascular and neurological complications.[2]

Abstract

The academic and clinical contributions of Nicola Cosentino are associated with contemporary developments in cardiovascular medicine, translational cardiology, and interdisciplinary biomedical sciences. His research portfolio demonstrates sustained engagement in acute coronary syndrome management, inflammatory biomarkers, cardiovascular imaging, metabolic dysfunction, acute kidney injury, and heart failure pathophysiology. Through collaborations with major cardiovascular institutions and international scientific groups, his work has contributed to improved understanding of prognostic indicators and therapeutic strategies relevant to cardiovascular and neurovascular disease mechanisms.[3]

Keywords

Cardiovascular Medicine, Translational Cardiology, Acute Myocardial Infarction, Neurocardiology, Precision Medicine, Heart Failure, Biomarkers, Acute Coronary Syndrome, Cardiovascular Inflammation, Cardio-Renal Syndrome, Clinical Research, Neuroscience Innovation, Cardiovascular Imaging, Metabolic Disorders, Intensive Cardiac Care.

Introduction

Nicola Cosentino graduated in Medicine with highest honors from the Catholic University of the Sacred Heart in Rome and subsequently specialized in cardiology while pursuing advanced translational medical research. His clinical and academic activities have been centered at Centro Cardiologico Monzino IRCCS in Milan, where he has held several positions related to intensive cardiac care, acute coronary syndrome management, and perioperative cardiology.[4]

His academic background combines clinical cardiology, translational medicine, biomarker research, and multidisciplinary therapeutic approaches. Over time, his work has increasingly incorporated emerging intersections between cardiovascular disease mechanisms and broader systemic pathophysiological processes, including inflammatory signaling, endothelial dysfunction, and organ interaction pathways relevant to neuroscience and vascular biology.[5]

Research Profile

Cosentino’s research profile reflects substantial scholarly productivity and international scientific engagement. His publication record includes peer-reviewed articles in journals such as European Heart Journal, JACC, International Journal of Cardiology, Cardiovascular Diabetology, Scientific Reports, and Journal of Clinical Medicine.[6]

His work frequently addresses clinical outcomes in myocardial infarction, diabetes-associated cardiovascular complications, platelet activation, inflammatory biomarkers, renal dysfunction, cardiovascular imaging, and translational therapeutic strategies. He has additionally participated in multicenter studies such as PROMISE, MATADOR-PCI, REOPEN-AMI, and AEGIS II, contributing to evidence-based cardiovascular practice and translational cardiovascular medicine.[7]

  • More than 150 peer-reviewed scientific publications.
  • h-index of 30 according to Scopus metrics.
  • Extensive contributions to acute coronary syndrome and heart failure research.
  • Participation in international multicenter cardiovascular trials.
  • Editorial and peer-review responsibilities in international biomedical journals.

Research Contributions

A major aspect of Cosentino’s scientific activity concerns acute myocardial infarction and associated cardiovascular complications. His investigations into inflammation, mitochondrial biomarkers, platelet activation, renal injury, and glycemic variability have contributed to the refinement of risk stratification frameworks in acute cardiac care.[8]

His work has also explored mechanistic pathways involving oxidative stress, endothelial dysfunction, macrophage biology, thrombosis, and vascular inflammation. These investigations have relevance not only for cardiovascular disease but also for emerging translational connections involving neurovascular and systemic inflammatory pathways associated with neurological disorders.[9]

In addition, Cosentino has contributed to clinical studies related to diabetes mellitus, chronic kidney disease, cardiorenal interactions, and cardiovascular outcomes associated with metabolic dysfunction. Several of these studies have evaluated long-term prognostic indicators and precision medicine strategies for individualized cardiovascular care.[10]

  • Research on acute coronary syndromes and myocardial infarction.
  • Investigations involving inflammatory and mitochondrial biomarkers.
  • Studies on platelet activation and endothelial dysfunction.
  • Clinical evaluation of cardio-renal interactions.
  • Contributions to translational cardiovascular medicine and precision cardiology.

Publications

Selected representative publications authored or co-authored by Nicola Cosentino include major contributions in cardiovascular medicine, translational biology, and clinical cardiology.[11]

  1. Cosentino N, Trombara F, De Metrio M, et al. Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists. Pharmaceuticals (Basel), 2025.
  2. Cosentino N, Campodonico J, Milazzo V, et al. Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications. Journal of Clinical Medicine, 2021.
  3. Brambilla M, Becchetti A, Rovati GE, Cosentino N, et al. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023.
  4. Cosentino N, Campodonico J, Moltrasio M, et al. High-Sensitivity C-Reactive Protein and Acute Kidney Injury in Patients with Acute Myocardial Infarction. Journal of Clinical Medicine, 2019.
  5. Marenzi G, Cosentino N, Bartorelli AL. Acute Kidney Injury in Patients with Acute Coronary Syndromes. Heart, 2015.

Research Impact

The research impact associated with Nicola Cosentino is reflected through citation metrics, interdisciplinary collaborations, clinical translational outcomes, and participation in international scientific initiatives. His publications have been cited extensively in cardiovascular and translational medicine literature, particularly in areas related to myocardial infarction, inflammatory signaling, cardiovascular biomarkers, and acute cardiac care.[12]

His scientific work has additionally contributed to evolving perspectives concerning vascular inflammation, systemic metabolic dysregulation, and organ interaction pathways relevant to neurological and cardiovascular disease progression. These multidisciplinary dimensions support the relevance of his research within emerging neuroscience-related biomedical fields.[13]

  • Scopus h-index of 30.
  • Nearly 3,000 scholarly citations.
  • International collaborations in cardiovascular medicine.
  • Editorial responsibilities in peer-reviewed scientific journals.
  • Research grants awarded by major scientific organizations and national institutions.

Award Suitability

Nicola Cosentino’s academic profile demonstrates sustained excellence in translational cardiovascular research, clinical innovation, and interdisciplinary biomedical investigation. His extensive publication record, clinical leadership roles, scientific collaborations, and contributions to acute cardiovascular medicine collectively support recognition within the framework of the World Neuroscientists Awards.[14]

His work reflects scientific rigor, translational relevance, and long-term contributions to patient-centered cardiovascular research. Furthermore, the integration of inflammation biology, vascular dysfunction, metabolic signaling, and organ-system interactions establishes meaningful relevance to contemporary neuroscience and neurovascular medicine research directions.[15]

Conclusion

Nicola Cosentino has established a substantial academic and clinical research profile characterized by interdisciplinary cardiovascular investigation, translational medicine contributions, and international scientific collaboration. His scholarly work has contributed to improved understanding of myocardial infarction, inflammatory cardiovascular disease, biomarker-guided prognosis, and cardio-renal interactions. The breadth and scientific consistency of his contributions support his recognition in international academic and biomedical award frameworks associated with neuroscience and translational medicine.[16]

References

  1. Elsevier. (n.d.). Scopus author details: Nicola Cosentino, Author ID 6602546905. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602546905
  2. ORCID. (n.d.). Nicola Cosentino ORCID profile.
    https://orcid.org/0000-0002-8628-3106
  3. Cosentino N, et al. (2025). Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists.
    https://doi.org/10.3390/ph18081202
  4. Centro Cardiologico Monzino. (n.d.). Clinical and academic activities of Nicola Cosentino.
    https://www.researchgate.net/profile/Nicola-Cosentino
  5. Cosentino N, et al. (2021). Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives. Nutrients.
    https://doi.org/10.3390/nu13103603
  6. Journal Citation Reports. (n.d.). Indexed journals featuring cardiovascular and translational medicine publications.
    https://directivepublications.org/journal-of-cardiovascular-diseases
  7. Montone RA, Cosentino N, et al. (2022). Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial.
    https://publires.unicatt.it/it/publications/precision-medicine-versus-standard-of-care-for-patients-with-myoc/
  8. Cosentino N, et al. (2021). Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications.
    https://doi.org/10.3390/jcm10020275
  9. Brambilla M, et al. (2024). Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment.
    https://www.jacc.org/doi/abs/10.1016/j.jacbts.2024.09.007
  10. Marenzi G, Cosentino N, et al. (2019). Reduced Cardiorenal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention.
    https://doi.org/10.2337/dc19-0047
  11. PubMed. (n.d.). Publication records for Nicola Cosentino.
    https://pubmed.ncbi.nlm.nih.gov/
  12. Scopus Analytics. (n.d.). Citation overview and research metrics for Nicola Cosentino.
    https://www.scopus.com/
  13. Falcão-Pires I, et al. (2024). Mechanisms of myocardial reverse remodelling and its clinical significance.
    https://pubmed.ncbi.nlm.nih.gov/38837573/
  14. World Neuroscientists Awards. (n.d.). International scientific recognition and award program.https://neuroscientists.net/
  15. Cosentino N, et al. (2023). Fluid balance in heart failure.
    https://pubmed.ncbi.nlm.nih.gov/37819223/
  16. Curriculum Vitae and academic publication records of Nicola Cosentino, Centro Cardiologico Monzino.
    https://www.cardiologicomonzino.it/

Olimpia Pino | Cognitive Rehabilitation | Research Excellence Award

Research Excellence Award

Olimpia Pino
University of Parma, Italy
Olimpia Pino
Affiliation University of Parma
Country Italy
Scopus ID 8433960200
Documents 29
Citations 349 citations by 332 documents
h-index 9
Subject Area Cognitive Rehabilitation
Event World Neuroscientists Awards
ORCID 0000-0003-3035-8401

Olimpia Pino is an Italian academic researcher and Associate Professor affiliated with the University of Parma, where her scholarly activities focus on cognitive psychology, neuropsychology, rehabilitation sciences, and cognitive neuroscience. Her academic work encompasses memory rehabilitation, emotional regulation, neurodevelopment, neurofeedback technologies, cognitive impairment, and behavioral psychology. Through interdisciplinary collaborations and scientific publications, Pino has contributed to the advancement of cognitive rehabilitation methodologies and the application of innovative technologies in neuroscience research.[1]

Her research portfolio includes studies involving mild cognitive impairment, post-traumatic stress disorder, emotional intelligence, virtual reality exposure therapy, social robotics, and neuroplasticity. The integration of behavioral science with technological interventions has remained a recurring theme in her academic contributions.[2]

Abstract

This academic recognition article presents an overview of the scholarly profile and research contributions of Olimpia Pino, Associate Professor at the University of Parma. Her work has addressed multiple dimensions of cognitive rehabilitation, memory processes, neuropsychological intervention, and behavioral sciences. Through interdisciplinary studies involving neurofeedback, virtual reality, social robotics, emotional regulation, and cognitive decline, Pino has contributed to contemporary discussions in neuroscience and rehabilitation sciences. Her publications and funded projects reflect sustained engagement with translational applications of cognitive and behavioral research.[3]

Keywords

Cognitive rehabilitation, neuropsychology, memory rehabilitation, mild cognitive impairment, neurofeedback, emotional regulation, PTSD, social robotics, behavioral neuroscience, virtual reality therapy, neuroplasticity, cognitive neuroscience, psychological rehabilitation, neuroscience technologies.

Introduction

The field of cognitive rehabilitation has increasingly integrated psychological science with technological innovation to improve clinical outcomes and enhance quality of life among individuals experiencing neurological and psychological disorders. Within this evolving domain, Olimpia Pino has contributed to research exploring the mechanisms of memory, cognitive functioning, emotional regulation, and neurodevelopment.[4]

At the University of Parma, Pino has participated in teaching, mentoring, and research activities associated with cognitive neuroscience and neuropsychology. Her academic appointments and responsibilities have included instruction in cognitive rehabilitation techniques, psychology, memory rehabilitation, and data analysis methods. These activities have supported interdisciplinary training within medicine, psychology, and rehabilitation sciences.[5]

Research Profile

Olimpia Pino’s academic profile is characterized by interdisciplinary research spanning psychology, neuroscience, rehabilitation, and cognitive technologies. Her investigations have explored neuropsychological rehabilitation, memory enhancement, social robotics, emotional processing, and digital therapeutic interventions.[6]

Her scholarly output includes journal articles, edited volumes, conference proceedings, and books focusing on cognitive processes, rehabilitation sciences, and applied behavioral analysis. Pino has also supervised and coordinated research projects involving neurofeedback systems, mild cognitive impairment interventions, and cognitive stimulation methodologies.[7]

  • Associate Professor at the University of Parma.
  • Research specialization in cognitive rehabilitation and neuropsychology.
  • Contributor to interdisciplinary studies involving neuroscience technologies and behavioral sciences.
  • Participant in scientific collaborations with international academic institutions.
  • Reviewer and editorial board member for neuroscience and rehabilitation journals.

Research Contributions

Pino has contributed to the development of rehabilitation-oriented neuroscience research through studies involving mild cognitive impairment, emotional regulation, and neuroplasticity. Her work on audio-visual entrainment and brain-computer interface systems explored alternative therapeutic strategies for anxiety, depression, and cognitive dysfunction.[8]

Additional investigations have examined the role of music stimulation in neurodevelopmental processes among preterm infants and maternal health contexts. These studies addressed prenatal auditory experiences and placental programming mechanisms in neonatal neurodevelopment.[9]

Pino also participated in research involving humanoid robots and artificial intelligence applications for cognitive stimulation programs in elderly populations with mild cognitive impairment. Such work integrated robotics with behavioral assessment and emotional recognition systems.[10]

  • Research on memory rehabilitation and prospective memory functioning.
  • Studies on PTSD, trauma, and emotional resilience.
  • Applications of social robotics in cognitive intervention programs.
  • Virtual reality exposure therapy for social anxiety disorder.
  • Neurofeedback and neuromodulation approaches for cognitive rehabilitation.
  • Behavioral and neuropsychological investigations involving emotional intelligence and digital behavior.

Publications

The publication record of Olimpia Pino includes peer-reviewed articles, conference proceedings, and academic books addressing cognitive neuroscience, neurorehabilitation, and behavioral sciences.[11]

  1. Pino, O. (2025). I sentieri dei ricordi. MUP, Parma.
  2. Pino, O., Bertoni, E., Diletto, P., Ferrari, L., Gaspari, M., & Pelosi, A. (2025). Early detection of cognitive impairment in the general population through a digital tool targeting prospective memory.
    https://doi.org/10.1080/07853890.2025.2525389
  3. Pino, O., Rossi, M., & Malvezzi, M. C. (2024). Does Trauma Change the Way Individuals with PTSD Deal with Positive Stimuli?
    https://doi.org/10.3390/bs14121195
  4. Pino, O., Squadroni, L., & Borghese, N.A. (2024). Design and implementation of a VR environment aimed at enhancing treatment of Social Anxiety Disorder.
  5. Pino, O., Di Pietro, S., & Poli, D. (2023). Effect of musical stimulation on placental programming and neurodevelopment outcome of preterm infants.
    https://doi.org/10.3390/ijerph20032718
  6. Pino, O., Trevino, R., & Poli, D. (2022). A comprehensive review on multifaceted mechanisms involved in breast cancer following adverse childhood experiences.
    https://doi.org/10.3390/ijerph191912615
  7. Pino, O. (2021). Is Zoom Dysmorphia a new disorder?
    https://doi.org/10.23750/abm.v92i6.12618
  8. Pino, O., Palestra, G., Trevino, R., & De Carolis, B. (2020). The humanoid robot NAO as trainer in a memory program for elderly people with Mild Cognitive Impairment.
    https://doi.org/10.1007/s12369-019-00533-y

Research Impact

The research activities of Olimpia Pino demonstrate measurable scholarly visibility through citations, interdisciplinary collaborations, and contributions to rehabilitation-oriented neuroscience literature. Her publications have addressed clinically relevant themes associated with aging, cognitive decline, emotional disorders, neurodevelopment, and technological innovation.[12]

Her research on cognitive stimulation assisted by humanoid robots and virtual reality-based therapies reflects ongoing developments in digital rehabilitation and assistive neuroscience technologies. These studies contribute to broader discussions regarding accessibility, patient engagement, and personalized therapeutic strategies.[13]

  • 349 scholarly citations across indexed academic databases.
  • h-index of 9 reflecting sustained research visibility.
  • Contributions to neuroscience, rehabilitation, and behavioral psychology journals.
  • Participation in interdisciplinary and international scientific collaborations.
  • Editorial and peer-review responsibilities within rehabilitation and psychology journals.

Award Suitability

The academic profile of Olimpia Pino demonstrates alignment with the objectives of the World Neuroscientists Awards, particularly in the areas of cognitive rehabilitation, translational neuroscience, and interdisciplinary scientific innovation. Her body of work reflects long-term engagement with rehabilitation-oriented neuroscience and the application of emerging technologies in cognitive and behavioral health.[14]

Her scholarly contributions, research leadership, teaching activities, and interdisciplinary collaborations collectively support recognition within international neuroscience and rehabilitation communities. The integration of neuropsychology, behavioral science, and digital technologies remains a defining characteristic of her academic work.[15]

Conclusion

Olimpia Pino has contributed to the advancement of cognitive rehabilitation and neuroscience research through interdisciplinary investigations addressing memory, emotional regulation, neurodevelopment, and rehabilitation technologies. Her academic activities at the University of Parma, combined with her publication record and scientific collaborations, illustrate a sustained commitment to neuroscience research and applied psychological sciences.[16]

The integration of behavioral approaches with innovative rehabilitation methodologies has positioned her work within contemporary discussions surrounding cognitive health, assistive technologies, and neuropsychological intervention strategies.

References

  1. Elsevier. (n.d.). Scopus author details: Olimpia Pino, Author ID 8433960200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=8433960200
  2. University of Parma. (2026). Academic curriculum vitae and institutional profile of Olimpia Pino.
  3. Pino, O. et al. (2025). Early detection of cognitive impairment in the general population through a digital tool targeting prospective memory.https://doi.org/10.1080/07853890.2025.2525389
  4. Pino, O. (2015). Memory impairments and rehabilitation: evidence-based effects of approaches and training programs.https://doi.org/10.2174/1874943720150601E001
  5. University of Parma. Teaching and academic appointments of Olimpia Pino.
  6. Pino, O., Palestra, G., Trevino, R., & De Carolis, B. (2020). The humanoid robot NAO as trainer in a memory program for elderly people with Mild Cognitive Impairment.https://doi.org/10.1007/s12369-019-00533-y
  7. Pino, O. (2017). Ricucire i ricordi. La memoria, i suoi disturbi, evidenze di efficacia dei trattamenti riabilitativi. Mondadori Università.
  8. Pino, O. (2017). Neuro-Upper, a novel technology for audio-video entrainment.
  9. Pino, O., Di Pietro, S., & Poli, D. (2023). Effect of musical stimulation on placental programming and neurodevelopment outcome of preterm infants.https://doi.org/10.3390/ijerph20032718
  10. Castellano, G., De Carolis, B., Macchiarulo, N., & Pino, O. (2022). Detecting emotions during cognitive stimulation training with the Pepper robot.https://doi.org/10.1007/978-3-030-96359-0_5
  11. Curriculum Vitae of Olimpia Pino. University of Parma Academic Documentation.
  12. Scopus Citation Metrics for Olimpia Pino.https://www.scopus.com/authid/detail.uri?authorId=8433960200
  13. Pino, O., Squadroni, L., & Borghese, N.A. (2024). Design and implementation of a VR environment aimed at enhancing treatment of Social Anxiety Disorder.
  14. World Neuroscientists Awards. Recognition criteria and academic excellence initiatives.https://neuroscientists.net
  15. Pino, O., Cunegatti, F., & D’Angelo, M. (2022). The role of life meaning in psychological distress and post-traumatic growth among Italian first-aid volunteers during the COVID-19 outbreak.https://doi.org/10.1007/s43076-022-00182-7
  16. Pino, O. & Romano, G. (2022). Engagement and arousal effects in predicting the increase of cognitive functioning following a neuromodulation program.https://doi.org/10.23750/abm.v93i3.13145